Cardiovascular health effects of oral and pulmonary exposure to multi-walled carbon nanotubes in ApoE-deficient mice

Tidsskriftartikel - 2016

Resume

Exposure to high aspect ratio nanomaterials, such as multi-walled carbon nanotubes (MWCNTs) may be associated with increased risk of atherosclerosis, pulmonary disease, and cancer. In the present study, we investigated the cardiovascular and pulmonary health effects of 10 weeks of repeated oral or pulmonary exposures to MWCNTs (4 or 40mug each week) in Apolipoprotein E-deficient (ApoE-/-) mice fed a Western-type diet. Intratracheal instillation of MWCNTs was associated with oxidative damage to DNA in lung tissue and elevated levels of lipid peroxidation products in plasma, whereas the exposure only caused a modest pulmonary inflammation in terms of increased numbers of lymphocytes in bronchoalveolar lavage fluid. Ultrasound imaging in live animals revealed an increase in the inner and outer wall thickness of the aortic arch at 10 weeks after pulmonary exposure to MWCNTs, which may suggest artery remodelling. However, we did not find accelerated plaque progression in the aorta or the brachiocephalic artery by histopathology. Furthermore, repeated oral exposure to MWCNTs did not cause changes in the composition of gut microbiota of exposed mice. Collectively, this study indicates that repeated pulmonary exposure to MWCNTs was associated with oxidative stress, whereas cardiovascular effects encompassed remodelling of the aorta wall

Reference

Christophersen DV, Jacobsen NR, Andersen MHG, Connell S, Barfod KK, Thomsen M, Miller M, Duffin R, Lykkesfeldt J, Vogel UB, Wallin EHR, Loft S, Roursgaard M, Moller P. Cardiovascular health effects of oral and pulmonary exposure to multi-walled carbon nanotubes in ApoE-deficient mice. Toxicology 2016;371:29-40.
doi: 10.1016/j.tox.2016.10.003

Gå til Tidsskriftartikel

Relaterede projekter

Dansk Center for Nanosikkerhed

NFA logo

Det Nationale Forskningscenter for Arbejdsmiljø | Lersø Parkallé 105 | 2100 København Ø. | T: 39 16 52 00 | F: 39 16 52 01 | M: nfa@nfa.dk | CVR: 15 41 37 00